Proton Pump Inhibitors and the Risk of Neoplastic Progression in Barrett's Esophagus: Results of a Large Multicenter Prospective Cohort Study

G A A b st ra ct s lesion does not appear to impact the frequency of change in diagnosis. Based on the potential to make an accurate histological diagnosis and thus allowing for better patient selection, EMR should be considered as the first step in the management of BE-associated early neoplasia irrespective of presence or absence of endoscopically visible lesions. Table 1: Frequency of change in diagnosis by EMR in patients with HGD on biopsy